Cases & Deals

Société Générale, Kempen, and Trout Capital complete €29.9 million private placement of new and secondary shares by DBV Technologies

Clients Société Générale SA, Kempen & Co., and Trout Capital

Jones Day represented Société Générale, Kempen & Co., and Trout Capital in connection with a €29.9 million (US$40.1 million) private placement of new and secondary shares by DBV Technologies, a biotech company specializing in food allergy with innovative products for diagnosis and treatment.